Binuclear complexes [Cp* 2 Rh 2 (μ-CA)Cl 2 ] ( 2a ) and [( p -cymene) 2 Ru 2 (μ-CA)Cl 2 ] ( 2b ) (CA = chloranilate) were obtained by the reactions of [Cp*RhCl(μ-Cl)] 2 ( 1a ) or [( p -cymene)RuCl(μ-Cl)] 2 ( 1b ) with H 2 CA in the presence of base, respectively. Treatment of 2a or 2b with bidentate ligands (L) such as pyrazine, 4,4′-dipyridine (bpy), 2,5-bis(4-pyridyl)-1,3,5-oxadiazole (bpo), and E -1,2-bis(4-pyridyl)ethene (bpe) in the presence of AgOTf (OTf = CF 3 SO 3 ) in CH 3 OH gave the corresponding tetranuclear complexes, with the general formulas [Cp* 4 Rh 4 (μ-CA) 2 (μ-L) 2 ](OTf) 4 ( 3a − d ) and [( p -cymene) 4 Ru 4 (μ-CA) 2 (μ-L) 2 ](OTf) 4 ( 4a − d ), respectively. The molecular structures of [Cp* 4 Rh 4 (μ-CA) 2 (μ-bpy) 2 ](OTf) 4 ( 3b ), [( p -cymene) 4 Ru 4 (μ-CA) 2 (μ-bpy) 2 ](OTf) 4 ( 4b ), and [( p -cymene) 4 Ru 4 (μ-CA) 2 (μ-bpe) 2 ](OTf) 4 ( 4d ) have been determined by single-crystal X-ray analysis and revealed that the metal centers were connected by pyridyl ligands and bis-bidentate chloranilate (CA) ligands to construct a rectangular cavity with different dimensions and strong π interactions between independent molecules to form rectangle channels in the solid state.
No takes yet. Share an insight, caveat, or question.
Han et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: